NEW ORLEANS — A consumer is suing the manufacturers and distributors of the drug Xarelto, alleging they failed to publicize its dangerous side effects.
Jeanette Wolcott filed a lawsuit April 13 in U.S. District Court for the Eastern District of Louisiana against Janssen Research & Development LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Bayer Healthcare Pharmaceuticals, Inc., Bayer Pharma AG, Bayer Corporation, Bayer Healthcare LLC, Bayer Healthcare AG and Bayer AG, alleging breach of express and implied warranty, fraudulent misrepresentation and concealment, fraud and deceit.
According to the complaint, Wolcott used Xarelto starting Dec. 22, 2011, up until approximately Jan. 24, 2012. As a result of using Xarelto, the suit says, she has suffered serious and dangerous side effects including life-threatening bleeding as well as other severe and personal injuries that are permanent and lasting in nature, plus physical pain and mental anguish.
The plaintiff alleges the defendants, who designed, researched, manufactured, tested, advertised, promoted, marketed, distributed and sold Xarelto, failed to properly investigate, research, study and define the safety profile of the drug, failed to adequately test it, failed to provide adequate warnings, failed to disclose the need for dose adjustments, failed to disclose the need to twice daily dosage and failed to provide adequate instructions.
Wolcott seeks a trial by jury, compensation for damages, medical expenses, out-of-pocket expenses, pre-judgment and post-judgment interest, attorney fees, costs and all other costs the court deems proper. She is represented by attorney Charles M. Thomas of Huber, Slack, Thomas & Marcelle LLP in New Orleans.
U.S. District Court for the Eastern District of Louisiana Case number 2:16-cv-03056